Rex Health Ventures

Pryon Inc. is an artificial intelligence company headquartered in Raleigh, North Carolina, that specializes in augmented intelligence solutions for enterprises. Founded in 2017, Pryon has developed a platform that enhances the capabilities of employees by facilitating access to knowledge and streamlining workflows. The platform intelligently orchestrates information across various channels and sources, utilizing advanced AI techniques such as natural language processing and context awareness. This enables organizations to navigate unstructured data more effectively, improve decision-making, and reduce operational complexities and costs. Through its innovative approach, Pryon aims to support businesses in their digital transformation efforts by making knowledge more accessible and actionable.

Pryon Inc. is an artificial intelligence company headquartered in Raleigh, North Carolina, that specializes in augmented intelligence solutions for enterprises. Founded in 2017, Pryon has developed a platform that enhances the capabilities of employees by facilitating access to knowledge and streamlining workflows. The platform intelligently orchestrates information across various channels and sources, utilizing advanced AI techniques such as natural language processing and context awareness. This enables organizations to navigate unstructured data more effectively, improve decision-making, and reduce operational complexities and costs. Through its innovative approach, Pryon aims to support businesses in their digital transformation efforts by making knowledge more accessible and actionable.

BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. BioStable was founded in

Bardy Diagnostics, Inc. is a medical device company that specializes in the development and manufacturing of cardiac monitoring solutions, primarily focused on arrhythmia detection. Its flagship product, the Carnation Ambulatory Monitor (CAM), is a lightweight, discreet cardiac patch that can be worn comfortably for up to seven days, even during physical activities like exercise or showering. The CAM is designed with a unique hourglass shape to enhance comfort, particularly for female patients. Complementing the monitor is the BDxCONNECT patient management system, which allows healthcare providers to create and manage patient reports efficiently. By utilizing innovative P-wave centric ECG detection technology, Bardy Diagnostics aims to improve clinical management and outcomes for patients and their physicians. Founded in 2013, the company is headquartered in Seattle, Washington, with additional offices in Houston, Texas, and New Providence, New Jersey.

Since 2013, Phynd has been on a mission to simplify provider data management for healthcare systems. Phynd 360 is an innovative provider data management platform that serves as the central hub for your providers. Phynd optimizes provider data – people, places and services – for use in EHR, Marketing and Claims systems via platform tools which offer provider enrollment, management, outreach and search across the enterprise. Today, over 350 hospitals and 20,000+ locations across the U.S utilize the Phynd 360 Provider Platform to maintain a single, centralized hub of all provider data. For more information, visit www.Phynd.com.

Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions aimed at enhancing patient outcomes during surgical procedures. Founded in 2011 and headquartered in Los Altos, California, Gauss has developed a vision-based platform that accurately measures surgical blood loss using advanced algorithms and artificial intelligence. Its flagship product, Triton, includes various models tailored for different medical settings, such as Triton OR for operating rooms and Triton L&D for labor and delivery. These devices assist healthcare professionals in early recognition of hemorrhage, provide objective metrics for blood loss, and inform transfusion decisions, ultimately improving patient safety and care quality. Gauss Surgical primarily serves the healthcare sector in the United States.

Emergo Therapeutics, Inc. is a pharmaceutical company based in Durham, North Carolina, founded in 2016. The company focuses on developing therapeutic drugs aimed at modulating inflammatory cytokines and enhancing immune system function. Its primary product in development is norketotifen, which is intended for the treatment of uncomplicated influenza and flu-like illnesses. Emergo Therapeutics seeks to reduce the production of inflammatory cytokines from mast cells, with a broader goal of addressing various infectious diseases and improving health outcomes related to inflammation.

TARGET PharmaSolutions, Inc. specializes in providing real-world data (RWD) solutions that facilitate drug development and commercialization. Established in 2015 and headquartered in Durham, North Carolina, the company creates customized datasets and analyses to address healthcare evidence questions. It offers a comprehensive health evidence solution that aggregates RWD from a network of clinical sites, alongside bio specimen samples and consulting services. The foundation of TARGET PharmaSolutions was influenced by the HCV-TARGET project, which began in 2011 and demonstrated the effectiveness of their model in Hepatitis C research. The initiative has garnered significant support, influencing labels for sponsors and helping to avoid costly Phase IV commitments. The FDA has actively engaged with the HCV-TARGET project, reflecting its relevance in clinical analysis and healthcare outcomes.

Phononic, Inc. specializes in the design, prototyping, and manufacturing of innovative cooling and heating solutions, focusing on solid-state technology. Founded in 2008 and based in Durham, North Carolina, the company develops thermoelectric devices and heat pumps that replace traditional compressor technology in various applications. Its products are utilized for electronics cooling in sectors such as optoelectronics and high-performance computing, as well as in healthcare, residential, and commercial refrigeration. Phononic's thermoelectric chips, made from bismuth telluride, offer sustainable and efficient temperature control without the use of toxic refrigerants, making them suitable for industries that require precise temperature management while reducing energy consumption. The company's approach aims to deliver smart and sustainable solutions for diverse climate control needs.

Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.

Arrivo BioVentures LLC is a biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development of biologics and small molecules aimed at enhancing patient outcomes. Founded in 2015, the company focuses on drug development, leveraging its expertise to create reformulated products, new chemical entities, and biologics. Arrivo BioVentures emphasizes the importance of collaboration with regulatory bodies, such as the FDA, to streamline the approval process and efficiently execute clinical programs. By proactively engaging with regulators, the company seeks to minimize unexpected challenges and accelerate the implementation of its development programs.

Veran Medical Technologies is a medical device company that specializes in developing minimally invasive devices for interventional oncology procedures. Headquartered in Saint Louis, Missouri, the company offers a range of products designed to assist physicians in diagnosing diseases and delivering therapies effectively. Its key offerings include the SPiNView thoracic navigation system, which facilitates biopsies of solitary pulmonary nodules for early lung cancer detection, and the ig4 IR System, an electromagnetic platform that aids in various procedures such as biopsies and ablations. Additionally, Veran provides tools like the SPiNPerc hybrid diagnostic device and vTrack 2.0 Instruments, which enhance the precision of lung procedures. The company's innovative technology generates dynamic 3D maps of respiratory airways, allowing for optimal planning and navigation during diagnostic processes. Established in 2003, Veran Medical Technologies focuses on improving patient outcomes through advanced image-guided medical devices.

Baebies, Inc. is a company that focuses on manufacturing screening and pediatric testing equipment for newborns. Established in 2014 and based in Durham, North Carolina, Baebies produces SEEKER, a laboratory solution for newborn screening that conducts multiple assays simultaneously by measuring lysosomal enzyme activity from a single dried blood spot. Additionally, the company offers FINDER, a near-patient testing device designed for pediatric applications. Baebies aims to enhance early disease detection and improve diagnostic capabilities through its innovative digital microfluidics technology, which optimizes the diagnostic yield from minimal blood samples. The company serves hospitals and public health laboratories, with a mission dedicated to saving lives and improving health outcomes for children by providing advanced testing solutions.

Baebies, Inc. is a company that focuses on manufacturing screening and pediatric testing equipment for newborns. Established in 2014 and based in Durham, North Carolina, Baebies produces SEEKER, a laboratory solution for newborn screening that conducts multiple assays simultaneously by measuring lysosomal enzyme activity from a single dried blood spot. Additionally, the company offers FINDER, a near-patient testing device designed for pediatric applications. Baebies aims to enhance early disease detection and improve diagnostic capabilities through its innovative digital microfluidics technology, which optimizes the diagnostic yield from minimal blood samples. The company serves hospitals and public health laboratories, with a mission dedicated to saving lives and improving health outcomes for children by providing advanced testing solutions.

Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.

Aerial BioPharma LLC is a biopharmaceutical company based in Morrisville, North Carolina, founded in 2011. The company specializes in drug development targeting conditions influenced by processes in the central nervous system. Aerial BioPharma is dedicated to creating both biologics and small molecules aimed at addressing various central nervous system disorders. Situated on the edge of Research Triangle Park, the company leverages its location to advance its research and development initiatives in this specialized field.